FDA deputy commissioner hints at potential changes to PDUFA
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationCompliancePDUFAPharmaceuticalsProduct developmentProduct LifecycleRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)